A study for a 69 year old woman who takes Potassium, Calan, Escitalopram, Lexapro, Valsartan - from FDA reports

11 females aged 69 (±5) who take the same drugs are studied. This is a personalized study for a 69 year old female patient who has Hypokalemia, Depression, Hypertension. The study is created by eHealthMe based on reports from FDA.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our independent and original studies have been referenced on 400+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO.

On May, 26, 2018

11 females aged 69 (±5) who take Potassium, Calan, Escitalopram, Lexapro, Valsartan are studied.

Number of reports submitted per year:

Potassium, Calan, Escitalopram, Lexapro, Valsartan for a 69-year old woman.

Information of the patient in this study:

  • Age: 69
  • Gender: female
  • Conditions: Hypokalemia, Depression, Hypertension
  • Drugs taken:
    • Potassium (potassium)
    • Calan (verapamil hydrochloride)
    • Escitalopram (escitalopram oxalate)
    • Lexapro (escitalopram oxalate)
    • Valsartan (valsartan)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
1 - 6 months:
6 - 12 months:
1 - 2 years:
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Pain
  2. Breathing difficulty
  3. Chest pain
  4. Sepsis (a severe blood infection that can lead to organ failure and death)
  5. Emotional distress

Top conditions involved for these people *:

  1. Cardiac Disorder : 4 people, 36.36%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 27.27%
  3. Weight Increased : 2 people, 18.18%
  4. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 18.18%
  5. High Blood Cholesterol : 2 people, 18.18%

Top co-used drugs for these people *:

  1. Lasix (6 people, 54.55%)
  2. Ambien (4 people, 36.36%)
  3. Nexium (3 people, 27.27%)
  4. Vitamin D (3 people, 27.27%)
  5. Soma (3 people, 27.27%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You are not alone: Connect with people like you, or share your experience to help people like you.

What are the drugs?

What are the conditions?

Related studies:

Related publications that referenced our studies

You may be interested in these posts

More posts for: Potassium, Calan, Escitalopram, Lexapro, Valsartan, Hypertension, Hypokalemia, Depression

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.